{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+C&page=12", "query": { "intervention": "Placebo- C", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 1833, "total_pages": 184, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+C&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+C&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T02:48:09.104Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01357642", "title": "Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "epinephrine inhalation aerosol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 373, "start_date": "2011-07", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2016-03-11", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 33, "location_summary": "Costa Mesa, California • Los Angeles, California • Mission Viejo, California + 30 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01357642" }, { "nct_id": "NCT06930625", "title": "A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acromegaly" ], "interventions": [ { "name": "Debio 4126", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2025-11-26", "completion_date": "2029-03", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 10, "location_summary": "Los Angeles, California • Chicago, Illinois • Boston, Massachusetts + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT06930625" }, { "nct_id": "NCT00662519", "title": "Neulasta in Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Neulasta (Pegylated)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mixed Meal Tolerance Test (MMTT)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Blood test", "type": "OTHER" }, { "name": "DNA Test", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 21, "start_date": "2008-04", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2015-04-09", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00662519" }, { "nct_id": "NCT06980428", "title": "A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants", "Dyslipidemia" ], "interventions": [ { "name": "AZD4954", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 136, "start_date": "2025-05-27", "completion_date": "2027-04-09", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 6, "location_summary": "Glendale, California • Inverness, Florida • Jacksonville, Florida + 3 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Inverness", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Port Orange", "state": "Florida" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06980428" }, { "nct_id": "NCT01740609", "title": "A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PF-06342674 Dose A", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose B", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose C", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose D", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose E", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose F", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose G", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose H", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose I", "type": "BIOLOGICAL" }, { "name": "PF-06342674 Dose J", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 80, "start_date": "2012-11", "completion_date": "2014-06", "has_results": false, "last_update_posted_date": "2014-06-19", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01740609" }, { "nct_id": "NCT05606757", "title": "A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ventral Hernia", "Abdominal Hernia" ], "interventions": [ { "name": "BOTOX Dose A", "type": "DRUG" }, { "name": "Placebo for BOTOX", "type": "DRUG" }, { "name": "BOTOX Dose B", "type": "DRUG" }, { "name": "BOTOX Dose C", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2024-05-07", "completion_date": "2025-09-26", "has_results": false, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 2, "location_summary": "Mineola, New York • Charlotte, North Carolina", "locations": [ { "city": "Mineola", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05606757" }, { "nct_id": "NCT01565681", "title": "Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics of ASKP1240", "Healthy Volunteers" ], "interventions": [ { "name": "ASP1240", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 109, "start_date": "2009-01", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2012-12-10", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01565681" }, { "nct_id": "NCT04678830", "title": "Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With \"Long\" COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronavirus Disease 2019" ], "interventions": [ { "name": "Placebos", "type": "DRUG" }, { "name": "Leronlimab (700mg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CytoDyn, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2021-03-01", "completion_date": "2021-07-08", "has_results": true, "last_update_posted_date": "2024-04-11", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 2, "location_summary": "Aventura, Florida • Gainesville, Georgia", "locations": [ { "city": "Aventura", "state": "Florida" }, { "city": "Gainesville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04678830" }, { "nct_id": "NCT03135834", "title": "A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Vaccine" ], "interventions": [ { "name": "MenABCWY", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "BIOLOGICAL" }, { "name": "rLP2086", "type": "BIOLOGICAL" }, { "name": "MenACWY-CRM", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 1610, "start_date": "2017-04-24", "completion_date": "2022-10-25", "has_results": true, "last_update_posted_date": "2023-08-08", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Fountain Hills, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Fountain Hills", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Harrisburg", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03135834" }, { "nct_id": "NCT00249106", "title": "Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infection" ], "interventions": [ { "name": "ADVAX", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "International AIDS Vaccine Initiative", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 45, "start_date": "2003-12", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2013-02-11", "last_synced_at": "2026-10-22T02:48:09.104Z", "location_count": 2, "location_summary": "New York, New York • Rochester, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00249106" } ] }